Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.39158 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.35593 | 14 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.35743 | 14 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.30364 | 14 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.3468 | 16 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.40797 | 14 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.36769 | 14 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.33409 | 14 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.32174 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.34631 | 14 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.51837 | 23 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.3256 | 14 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.34744 | 14 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.3519 | 15 |